Frequently Asked Questions
The market is segmented based on By Type (Standard Pen Needles and Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm and 12mm), Usability (Reusable Pen Needles and Disposable Pen Needles), Application (Diabetes, Growth Hormone Deficiency and Others), Therapy (Insulin Therapy, Glucagon-Like Peptide-1 Therapy, Growth Hormone Therapy and Other Therapies), Mode of Purchase (Retail and Non-Retail), End User (Hospitals, Clinics, Over The Counter (OTC), Home Healthcare and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands,Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
.
The Global Pen Needles Market size was valued at USD 0.00 USD Million in 2021.
The Global Pen Needles Market is projected to grow at a CAGR of 10.68% during the forecast period of 2022 to 2028.
The major players operating in the market include Novo Nordisk A/S, YPSOMED, B. Braun Melsungen AG, HTL-STREFA S.A., Terumo Corporation, BD, Owen Mumford , UltiMed , Artsana S.p.A., Trividia Health , and others,.
